Pharmacology: Antagonists and Agonists Quiz

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What effect does an antagonist have on the normal action of an agonist at a receptor?

  • It enhances the agonist's action.
  • It blocks the agonist's action. (correct)
  • It has no effect on the agonist's action.
  • It changes the agonist's action to a different effect.

Which type of antagonist binds to the same site as the agonist?

  • Competitive antagonist (correct)
  • Non-competitive antagonist
  • Irreversible antagonist
  • Allosteric antagonist

What distinguishes a competitive antagonist from a non-competitive antagonist?

  • Competitive antagonists bind to the active site, non-competitive antagonists bind to a different site. (correct)
  • Competitive antagonists are irreversible, non-competitive antagonists are reversible.
  • Competitive antagonists bind to a different site, non-competitive antagonists bind to the active site.
  • Competitive antagonists are reversible, non-competitive antagonists are irreversible.

What is the effect of an irreversible antagonist on the dose-response curve of an agonist?

<p>The curve shifts to the right and the maximum response is reduced. (C)</p> Signup and view all the answers

How does a non-competitive antagonist at an allosteric site affect the dose-response curve of an agonist?

<p>It reduces the slope of the curve. (A)</p> Signup and view all the answers

What is the primary difference between a pure antagonist and a partial agonist?

<p>Pure antagonists have no efficacy, whereas partial agonists have some efficacy. (D)</p> Signup and view all the answers

Which of the following is NOT a characteristic of a competitive antagonist?

<p>It forms irreversible bonds with the receptor. (A)</p> Signup and view all the answers

What is the primary mechanism by which non-competitive antagonists at allosteric sites exert their effect?

<p>Interfering with downstream signaling pathways. (D)</p> Signup and view all the answers

What kind of antagonist is protamine?

<p>Chemical (C)</p> Signup and view all the answers

What is the relationship between affinity and Kd?

<p>Affinity is inversely proportional to Kd (B)</p> Signup and view all the answers

Which of the following is an example of a physiological antagonist?

<p>Glucocorticoids and insulin (A)</p> Signup and view all the answers

What is the effect of a pure antagonist on a receptor?

<p>It blocks the receptor and prevents the agonist from binding. (C)</p> Signup and view all the answers

A quantal dose-response curve is used to analyze the response of...

<p>A population to a drug (D)</p> Signup and view all the answers

What is the therapeutic index of a drug?

<p>The ratio of the effective dose to the lethal dose (B)</p> Signup and view all the answers

What is the EC50 of a drug?

<p>The concentration of drug required to elicit a 50% maximum response (B)</p> Signup and view all the answers

How does a competitive antagonist affect the dose-response curve of an agonist?

<p>It shifts the curve to the right, increasing the EC50 (C)</p> Signup and view all the answers

What is the relationship between pA2 and Kb in the context of competitive antagonism?

<p>pA2 = -log Kb (A)</p> Signup and view all the answers

Under what condition does the relationship pA2 = -log Kb hold true?

<p>When the Schild plot exhibits linearity with a slope of 1. (B)</p> Signup and view all the answers

Which of the following factors can influence the extent of antagonist inhibition?

<p>All of the above (D)</p> Signup and view all the answers

How does the antagonist influence the agonist curve in the presence of an irreversible antagonist?

<p>The agonist curve maintains its shape but decreases in maximal response. (B)</p> Signup and view all the answers

Which of the following statements is true about irreversible antagonists?

<p>They lead to a permanent block of the receptor, independent of agonist concentration. (B)</p> Signup and view all the answers

What is the main consequence of irreversible antagonism on the agonist's effect?

<p>Reduced maximal response of the agonist. (A)</p> Signup and view all the answers

Why does the duration of effect for an irreversible antagonist depend on receptor turnover?

<p>Because antagonists bind irreversibly, their effect is determined by the rate of receptor synthesis. (C)</p> Signup and view all the answers

What is the significance of receptor reserves in the context of irreversible antagonism?

<p>They compensate for the loss of receptors due to irreversible antagonists. (A)</p> Signup and view all the answers

Which of the following statements accurately describes the therapeutic window of a drug?

<p>The range of doses that produces the desired therapeutic effect without causing toxicity. (D)</p> Signup and view all the answers

Which type of antagonist can be overcome by increasing the concentration of the agonist?

<p>Competitive antagonist (D)</p> Signup and view all the answers

The graph depicting the effect of Warfarin demonstrates that Warfarin has a:

<p>High efficacy and high potency. (D)</p> Signup and view all the answers

A Schild plot is used to quantify the effect of:

<p>Competitive antagonists (C)</p> Signup and view all the answers

Which of the following statements best describes the effect of an irreversible antagonist on the agonist-response curve?

<p>The curve is shifted to the right, with a reduced maximal asymptote. (C)</p> Signup and view all the answers

What is the primary difference between graded and quantal dose-response curves?

<p>All of the above. (D)</p> Signup and view all the answers

What is the relationship between the EC50 and drug potency?

<p>EC50 is inversely proportional to potency. (D)</p> Signup and view all the answers

Which of the following receptor types is NOT mentioned in the pharmacodynamic summary provided?

<p>Voltage-gated ion channels (C)</p> Signup and view all the answers

A non-competitive antagonist at an allosteric site would most likely cause which of the following effects?

<p>An increase in the EC50 and a reduction in the maximal effect. (C)</p> Signup and view all the answers

Which of the following is an example of a competitive antagonist?

<p>Both A and C (A)</p> Signup and view all the answers

What is the primary mechanism by which a non-competitive antagonist at an allosteric site exerts its effect?

<p>By altering the conformation of the receptor, making it less responsive to the agonist. (A)</p> Signup and view all the answers

In the context of drug therapy, what does a narrow therapeutic index (TI) indicate?

<p>The drug has a high risk of adverse effects, requiring careful monitoring. (A)</p> Signup and view all the answers

Which of the following scenarios best describes the effect of a full agonist on a receptor?

<p>The agonist binds to the receptor and produces the maximum possible response. (D)</p> Signup and view all the answers

What is the primary difference between a competitive and a non-competitive antagonist based on their effect on the dose-response curve?

<p>Competitive antagonists do not change the maximum effect while non-competitive antagonists reduce it. (C)</p> Signup and view all the answers

Which of the following best describes the effect of an irreversible antagonist on the dose-response curve of an agonist?

<p>It results in a reduction of the maximum effect of the agonist. (D)</p> Signup and view all the answers

What is the effect of increasing the concentration of a competitive antagonist on the dose-response curve of an agonist?

<p>The curve shifts to the right. (D)</p> Signup and view all the answers

What is the key characteristic of a competitive antagonist that allows its antagonism to be overcome by increasing the agonist concentration?

<p>Reversible binding to the receptor. (D)</p> Signup and view all the answers

In the context of a Schild plot, what does the term 'dose ratio' (r) represent?

<p>The ratio of the agonist concentration required to produce a given effect in the presence of the antagonist to the concentration required in the absence of the antagonist. (D)</p> Signup and view all the answers

What does the Schild equation tell us about the relationship between the dose ratio (r), the antagonist concentration ([B]), and the antagonist dissociation constant (Kb)?

<p>The dose ratio is directly proportional to the antagonist concentration and inversely proportional to the antagonist dissociation constant. (D)</p> Signup and view all the answers

In a Schild plot, what does the x-axis typically represent?

<p>The logarithm of the antagonist concentration ([B]). (A)</p> Signup and view all the answers

What is the significance of a pA2 value in the context of competitive antagonism?

<p>It represents the negative logarithm of the molar concentration of antagonist required to produce a dose ratio equal to 2. (B)</p> Signup and view all the answers

What does a Schild plot allow you to estimate about a competitive antagonist?

<p>The dissociation constant (Kb) of the antagonist from the receptor. (A)</p> Signup and view all the answers

What is the relationship between a competitive antagonist and the maximal response achievable by the agonist?

<p>The competitive antagonist has no effect on the maximal response of the agonist. (B)</p> Signup and view all the answers

Flashcards

Antagonism

A process where a drug blocks the response of an agonist.

Competitive Antagonism

Antagonist competes with an agonist for the same binding site on a receptor.

Non-competitive Antagonism

Antagonist binds to a different site, preventing the agonist from eliciting a response.

Dose-Response Curve

A graph showing the relationship between drug dose and its effect on the body.

Signup and view all the flashcards

Full Agonists

Compounds that bind to receptors and produce maximum response.

Signup and view all the flashcards

Partial Agonists

Compounds that bind and activate a receptor but produce a lower response than full agonists.

Signup and view all the flashcards

Quantal Dose Response Curve

A dose-response curve that represents the percentage of a population that responds to a drug.

Signup and view all the flashcards

Therapeutic Index

The ratio between the toxic dose and the therapeutic dose of a drug.

Signup and view all the flashcards

Pharmacological Antagonist

Blocks the normal action of an agonist on a receptor.

Signup and view all the flashcards

Pure Antagonist

Does not cause any action by itself when binding to receptor.

Signup and view all the flashcards

Irreversible Antagonist

Forms permanent bonds with receptors, preventing agonist action permanently.

Signup and view all the flashcards

Efficacy

The ability of a drug to activate a receptor and produce a response.

Signup and view all the flashcards

Schild equation

pA2 = - log Kb, used to measure antagonist potency.

Signup and view all the flashcards

Schild plot slope

Indicates relationship between agonist and competitive antagonist.

Signup and view all the flashcards

Concentration dependence

Antagonist inhibition effects vary with agonist concentration.

Signup and view all the flashcards

Agonist-receptor complex

Formation that leads to pharmacological action.

Signup and view all the flashcards

Reduced maximal response

Observed with irreversible antagonists; unable to reach full effect.

Signup and view all the flashcards

Receptor turnover

Rate at which receptors are replaced; affects antagonist duration.

Signup and view all the flashcards

EC50

Effective concentration for 50% maximal response.

Signup and view all the flashcards

Agonist

A substance that activates a receptor to produce a biological response.

Signup and view all the flashcards

Dose Ratio

The ratio of agonist concentration required to achieve a certain response in the presence of an antagonist.

Signup and view all the flashcards

Schild Plot

A graphical representation that plots the dose ratio against the logarithm of antagonist concentration.

Signup and view all the flashcards

pA2 value

A numerical value indicating the concentration of antagonist needed to double the EC50 of an agonist.

Signup and view all the flashcards

Receptor-Agonist Interaction

The process in which an agonist binds to a receptor, forming an active complex that triggers a response.

Signup and view all the flashcards

Forms of Antagonism

Chemical, physical, and pharmacological antagonism are the three forms.

Signup and view all the flashcards

Therapeutic Window

The dosage range between therapeutic effects and toxic effects.

Signup and view all the flashcards

Graded vs. Quantal Curves

Graded curves show effects of doses continuously, while quantal shows percentage of responders.

Signup and view all the flashcards

Therapeutic Index (TI)

A ratio that compares the toxic dose to the therapeutic dose, indicating drug safety.

Signup and view all the flashcards

Study Notes

Strand 1: General Principles of Pharmacology, Lecture 3: Antagonists and Dose-Response Curves

  • Antagonists are drugs that block the response of an agonist.
  • Examples include terfenadine at the H₁ receptor.
  • Pure antagonists do not cause any action by binding to the receptor.
  • Many clinically useful drugs are antagonists.

General Classes of Antagonists

  • Chemical: Binding two agents renders the active drug inactive; example: protamine binds (sequesters) heparin.
  • Physiological: Two agents with opposite effects cancel each other out; example: glucocorticoids and insulin.
  • Pharmacological: Binds to a receptor and blocks the normal action of an agonist on receptor responses.

Receptor Antagonists

  • Receptor Antagonists: These bind to receptors.
    • Active Site Binding:
      • Reversible: Binds reversibly.
      • Irreversible: Binds irreversibly.
    • Allosteric Binding:
      • Reversible: Binds reversibly.
      • Irreversible: Binds irreversibly.
  • Non-receptor Antagonists: These do not bind to receptors directly.
    • Chemical: Binding of two agents renders the active drug inactive.
    • Physiological: Two agents with opposite effects cancel each other out.

Competitive Antagonism

  • Mechanism: Competes with agonists for the same receptor binding site.
  • Effect on Dose-Response Curve: Causes a parallel shift to the right of the agonist response curve.
  • Overcoming Antagonism: Increasing agonist concentration can overcome the competitive antagonism.
  • Schild Plot: A graphical method to determine if a drug is a competitive antagonist.

Non-Competitive Antagonism

  • Mechanism: Binds to a different site on the receptor, altering the receptor's ability to bind the agonist.
  • Effect on Dose-Response Curve: Causes a parallel shift to the right of the agonist response curve and reduces the maximal response.
  • Overcoming Antagonism: Increasing agonist concentration will not overcome the antagonism.

Irreversible Antagonism

  • Mechanism: Binds irreversibly to the receptor.
  • Effect on Dose-Response Curve: A parallel shift to the right of the agonist response curve with a reduced maximal response.
  • Characteristics: The effect of the antagonist is not reversed by increasing the agonist concentration. The duration of the antagonism is related to receptor turnover.

Efficacy and Antagonists

  • Pure antagonists do not cause any action by themselves when they bind to a receptor.
  • Have no efficacy.
  • Full agonists have high efficacy, partial agonists have lower efficacy.

Therapeutic Window/Index

  • The ratio of the dose that produces a toxic effect (TD50) to the dose that produces a therapeutic effect (ED50).
  • A larger therapeutic window is better; it means the dose needed to produce a toxic effect is much larger than the dose needed for a therapeutic effect.

Key Points

  • Antagonism exists in three forms: chemical, physical, and pharmacological.
  • Pharmacological antagonists do not act on a target directly but instead prevent the binding and action of other endogenous compounds.
  • Competitive antagonists cause a parallel shift in the agonist-response curve and can be overcome by increasing agonist concentration.
  • Irreversible antagonists cause a parallel shift in the agonist-response curve with a reduced maximum response, which cannot be overcome increasing agonist concentration.
  • The therapeutic window defines the range of doses between therapeutic and toxic effects.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

More Like This

Use Quizgecko on...
Browser
Open
Browser
Browser